Related Experiment Videos
Dexamethasone suppression in dementia, depression, and normal aging
The American Journal of Psychiatry
|April 1, 1986
Summary
Dexamethasone suppression tests reveal distinct cortisol patterns in elderly individuals. Depressed patients showed higher nonsuppression rates, while demented patients exhibited intermediate levels compared to healthy controls.
Area of Science:
- Gerontology
- Neuroscience
- Endocrinology
Background:
- The dexamethasone suppression test (DST) is a biomarker for depression.
- Age-related changes can influence DST results, complicating interpretation in elderly populations.
Purpose of the Study:
- To investigate DST performance in elderly patients with moderate dementia and depression.
- To compare DST results between demented, depressed, and healthy elderly individuals.
Main Methods:
- Administered DST to 18 moderately demented elderly patients, 66 depressed elderly outpatients, and 25 healthy elderly controls.
- Measured postdexamethasone plasma cortisol levels in all participants.
- Analyzed DST nonsuppression rates and cortisol levels across diagnostic groups.
Main Results:
- DST nonsuppression rates were 17% in demented patients, 4% in controls, and 38% in depressed patients.
- Demented patients had intermediate postdexamethasone cortisol levels compared to depressed and control groups.
- Older subjects across all groups exhibited higher postdexamethasone cortisol levels.
Conclusions:
- DST may offer differential diagnostic insights in elderly patients with cognitive and mood disorders.
- Age is a significant factor influencing DST outcomes in the elderly, irrespective of diagnosis.